
    
      This is a multicenter, prospective, randomized, open study

      After the permeabilization of the clinical event responsible artery patients will be
      randomized in a 1:1 ratio to one of the following treatment groups:

      Group 1: insertion of a bare metal stent with post-dilatation with a paclitaxel eluting
      balloon (Pantera Lux Â®)

      Group 2: insertion of a drug elution stent

      Patients (or their legal representative) must sign the consent before randomization.

      Patients will be monitored 30 days after surgery, at 6 and 12 months.

      The primary efficacy endpoint is Target Vessel Failure (TVF) at 12 months

      This study will involve patients over 18 years old with STEMI, or new left bundle branch
      block or posterior AMI (ECG) that occur within 12 hours of onset of symptoms.

      A total of 516 patients will be included.
    
  